Physician

Altin Pani, M.D.

According to 2025 Medicare claims, Altin Pani, M.D. (NPI: 1912174897) practices ophthalmology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Providence, RI. This provider's primary affiliated billing organization is RETINA CONSULTANTS INC (NPI: 1780765354; TIN: 050380297) and primary practice location at 02864-1423. Pani is affiliated with the Lifespan Health Alliance, LLC (ACO ID: A3336), participating under the MSSP model.

Pani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 731 traditional Medicare patients, billed 12,477 HCPCS/CPT codes, and received $1,776,763 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 278 prescription claims across 98 beneficiaries totaling $9,347 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $3,196 to $9,347. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$936K$1.9M2015 Medicare payment: $1,400,652 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,602,425 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,674,443 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,758,216 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,872,107 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,800,310 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,867,970 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,691,387 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,698,549 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,776,763 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156937,075$1,400,652
20167587,096$1,602,425
20176317,204$1,674,443
20186276,936$1,758,216
20197088,046$1,872,107
20207657,637$1,800,310
20218178,145$1,867,970
20227397,875$1,691,387
202375311,135$1,698,549
202473112,477$1,776,763

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.6K$11K2015 Drug cost: $3,196 (USD; Tot_Drug_Cst)2016 Drug cost: $3,333 (USD; Tot_Drug_Cst)2017 Drug cost: $3,957 (USD; Tot_Drug_Cst)2018 Drug cost: $4,913 (USD; Tot_Drug_Cst)2019 Drug cost: $5,674 (USD; Tot_Drug_Cst)2020 Drug cost: $9,440 (USD; Tot_Drug_Cst)2021 Drug cost: $9,145 (USD; Tot_Drug_Cst)2022 Drug cost: $10,325 (USD; Tot_Drug_Cst)2023 Drug cost: $11,229 (USD; Tot_Drug_Cst)2024 Drug cost: $9,347 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152951$3,196
20163164$3,333
20173798$3,957
201851126$4,913
201965156$5,674
202092227$9,440
202197255$9,145
2022114296$10,325
2023109318$11,229
202498278$9,347

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1791,912$652
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7897$93
92014Established patient complete exam of visual system567800$90
67028Injection of drug into eye2401,275$89
92134Imaging of retina6922,023$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate964,475$5,196
Brimonidine TartrateBrimonidine Tartrate653,026$744
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat302,106$670
Dorzolamide HclDorzolamide Hcl11670$280
ErythromycinErythromycin Base16221$195

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Altin Pani, M.D.?

Tedicare shows public-source Medicare data for Altin Pani, M.D. (NPI 1912174897), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Altin Pani, M.D. have ACO affiliation data?

Altin Pani, M.D. is shown with ACO affiliation data for Lifespan Health Alliance, LLC (MSSP, ACO ID A3336).

What billing organization is linked to Altin Pani, M.D.?

Altin Pani, M.D. is linked to RETINA CONSULTANTS INC (billing NPI 1780765354) in the available physician profile data.

Does Altin Pani, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.